172 related articles for article (PubMed ID: 12667245)
1. Performance of drug resistance assays in testing HIV-1 non-B subtypes.
Holguín A; Hertogs K; Soriano V
Clin Microbiol Infect; 2003 Apr; 9(4):323-6. PubMed ID: 12667245
[TBL] [Abstract][Full Text] [Related]
2. Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.
Brindeiro PA; Brindeiro RM; Mortensen C; Hertogs K; De Vroey V; Rubini NP; Sion FS; De Sá CA; Machado DM; Succi RC; Tanuri A
J Clin Microbiol; 2002 Dec; 40(12):4512-9. PubMed ID: 12454144
[TBL] [Abstract][Full Text] [Related]
3. Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda.
Weidle PJ; Downing R; Sozi C; Mwebaze R; Rukundo G; Malamba S; Respess R; Hertogs K; Larder B; Ochola D; Mermin J; Samb B; Lackritz E
AIDS; 2003 Jul; 17 Suppl 3():S39-48. PubMed ID: 14565608
[TBL] [Abstract][Full Text] [Related]
4. Resistance of human immunodeficiency virus type 1 to reverse transcriptase and protease inhibitors: genotypic and phenotypic testing.
García-Lerma JG; Heneine W
J Clin Virol; 2001 Jun; 21(3):197-212. PubMed ID: 11397656
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.
Salomon H; Wainberg MA; Brenner B; Quan Y; Rouleau D; Coté P; LeBlanc R; Lefebvre E; Spira B; Tsoukas C; Sekaly RP; Conway B; Mayers D; Routy JP
AIDS; 2000 Jan; 14(2):F17-23. PubMed ID: 10708278
[TBL] [Abstract][Full Text] [Related]
6. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.
Gallego O; Ruiz L; Vallejo A; Ferrer E; Rubio A; Clotet B; Leal M; Soriano V;
AIDS; 2001 Sep; 15(14):1894-6. PubMed ID: 11579258
[TBL] [Abstract][Full Text] [Related]
7. Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors.
Peduzzi C; Pierotti P; Venturi G; Romano L; Mazzotta F; Zazzi M
J Clin Virol; 2002 Jul; 25(1):57-62. PubMed ID: 12126722
[TBL] [Abstract][Full Text] [Related]
8. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
[TBL] [Abstract][Full Text] [Related]
9. Time trends in primary HIV-1 drug resistance among recently infected persons.
Grant RM; Hecht FM; Warmerdam M; Liu L; Liegler T; Petropoulos CJ; Hellmann NS; Chesney M; Busch MP; Kahn JO
JAMA; 2002 Jul; 288(2):181-8. PubMed ID: 12095382
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.
Kantor R; Katzenstein D
AIDS Rev; 2003; 5(1):25-35. PubMed ID: 12875105
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 drug resistance in newly infected individuals.
Boden D; Hurley A; Zhang L; Cao Y; Guo Y; Jones E; Tsay J; Ip J; Farthing C; Limoli K; Parkin N; Markowitz M
JAMA; 1999 Sep 22-29; 282(12):1135-41. PubMed ID: 10501116
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients who have rebound in viral load while receiving antiretroviral therapy in the UNAIDS-Drug Access Initiative in Abidjan, Côte d'Ivoire.
Adjé-Touré C; Celestin B; Hanson D; Roels TH; Hertogs K; Larder B; Diomande F; Peeters M; Eholié S; Lackritz E; Chorba T; Nkengasong JN
AIDS; 2003 Jul; 17 Suppl 3():S23-9. PubMed ID: 14565606
[TBL] [Abstract][Full Text] [Related]
13. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes.
Holguín A; Ramirez de Arellano E; Rivas P; Soriano V
AIDS Rev; 2006; 8(2):98-107. PubMed ID: 16848277
[TBL] [Abstract][Full Text] [Related]
15. Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs.
Dunne AL; Mitchell FM; Coberly SK; Hellmann NS; Hoy J; Mijch A; Petropoulos CJ; Mills J; Crowe SM
AIDS; 2001 Aug; 15(12):1471-5. PubMed ID: 11504978
[TBL] [Abstract][Full Text] [Related]
16. In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.
Elbeik T; Hoo BS; Campodonico ME; Dileanis J; Fay FF; Bortolozzi RL; Benetti MS; Fay OH; Marlowe N; Petrauskene O; Chernoff D; Smith L; Ng VL
J Hum Virol; 2001; 4(6):317-28. PubMed ID: 12082398
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral drug resistance among HIV-1 infected children failing treatment.
Mullen J; Leech S; O'Shea S; Chrystie IL; Du Mont G; Ball C; Sharland M; Cottam F; Zuckerman M; Rice P; Easterbrook P
J Med Virol; 2002 Nov; 68(3):299-304. PubMed ID: 12226814
[TBL] [Abstract][Full Text] [Related]
18. Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals.
Simon V; Vanderhoeven J; Hurley A; Ramratnam B; Louie M; Dawson K; Parkin N; Boden D; Markowitz M
AIDS; 2002 Jul; 16(11):1511-9. PubMed ID: 12131189
[TBL] [Abstract][Full Text] [Related]
19. Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients.
Epaulard O; Signori-Schmuck A; Larrat S; Kulkarni O; Blum MG; Fusillier K; Blanc M; Leclercq P; François O; Morand P
J Clin Virol; 2017 Oct; 95():13-19. PubMed ID: 28830014
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance in non-subtype B HIV-1.
Kantor R; Katzenstein D
J Clin Virol; 2004 Mar; 29(3):152-9. PubMed ID: 14962783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
